
According to the Centers for Disease Control (CDC), an estimated 30 million people in the US have diabetes (9% of the US population). Only 23 million have an official diagnosis, while 7 million are undiagnosed. The prevalence of diabetes is highest in American Indians/Alaskan Natives at 15%, followed by African Americans (13%), people of Hispanic ethnicity (12%) and Caucasians (7%).
An estimated 84 million people in the US have prediabetes (34% of the population) – including nearly half of adults aged 65 years old and older. The prevelance of diabetes is increasing – by the year 2050, as much as 33% of the population will have the disease. This has significant implications on the long term micro- and macrovascular complications, coexisting health conditions, and costs associated with diabetes. In fact, the total healthcare costs of diagnosed diabetes increased 26% from 2012 to 2017, to $327 billion. People with diabetes incur medical expenses that are 2.3 times higher than those of individuals without diabetes. Because the population most affected by the increase in diabetes prevalence and costs are adults aged 65 years, it has a major impact on our Medicare program.
Fee
CE Hours
CE Units
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists, Nurse Practitioners, Clinical Nurse Specialists, and Registered Nurses
Accreditation(s)
CE activities for Pharmacists and Pharmacy Technicians:
This continuing education (CE) activity meets the requirements of all state boards of pharmacy for approved continuing education hours. CE credit is automatically reported to CPE Monitor.
The American Nurses Credentialing Center (ANCC) for formally approved continuing education (CE) hours, and CE hours of pharmacotherapeutics.
The American Academy of Nurse Practitioners Certification Program (AANPCP) for acceptable, accredited CE.
- The ANCC requires all advanced practice nursing certificants (CNSs and NPs) to complete 25 CE hours of pharmacotherapeutics as a portion of the required 75 continuing education hours.
- Pharmacology CE is recommended by the AANPCP and will be required for Certificants renewing certification starting January 2017.
- Most State Boards of Nursing require a minimum number of pharmacy contact hours to renew an advanced practice license.

Requirements for CE Credit
Objectives
- Discuss the intention of patient-centered, comprehensive care for individuals with diabetes. Summarize the new recommendations for patients with diabetes who also have dyslipidemia and/or hypertension.
- Describe specific cardiovascular and/or chronic kidney disease benefits of glucagon-like peptide-1 (GLP-1) agonists and sodium glucose cotransporter-2 (SGLT-2) inhibitors, as outlined in the ADA Standards of Care.
- Discuss the insulin therapy updates in the ADA Standards of Care, including new considerations for older adults.
Speaker(s)/Author(s)
Katherine O’Neal, PharmD, MBA, BCACP, CDE, BC-ADM, AE-C, CLS Brief Bio : Katherine O’Neal, PharmD, MBA, BCACP, CDE,BC-ADM, AE-C, CLS, FAADE is an Associate Professor in the Department of Pharmacy, Clinical and Administrative Sciences at the University of Oklahoma College of Pharmacy, Oklahoma City, OK. She is a Diabetes Care and Education Specialist with the certifications CDE and BC-ADM. |
Activity Number
0428-0000-20-001-H01-P